Abstract
Overview
Money is starting to flow. The 8.2 billion dollars appropriated to the NIH
Scientific Research program by the American Recovery and Reinvestment Act is
being earmarked for lab renovations, Challenge Grants, the Shared
Instrumentation Program and research that spans multiple public and non-profit
institutions - all of which will have an immediate and long-term impact on the
life science tools industry. Unlike the tumultuous first quarter of 2009, the
current climate bodes well for the life science industry, and suppliers can
strategize with increased confidence as we move into a more clearly defined -
and better funded - 2010.
Across the board, suppliers are sensing that lab purchasing agents have a
better understanding of sources of funding and how monies will be spent than
they did a year ago. In our upcoming report, The Market Outlook for
Research Products in FY2010, we asked nearly 800 scientists detailed
questions about their FY2010 budgets, planned expenditures and sources of
funding. Applicable to both product development and marketing, this report
short-circuits the decision-making process by providing financial data that
supports a strategy predicated on what scientists plan to buy. Furthermore,
excerpts from this study can inform reporting - to management teams, boards of
directors, analysts and investors.
The Market Outlook for Research Products in FY2010 compares and
contrasts FY2009 (actual) and FY2010 projected) budgets - in total, and by
product category with a special focus on market segment and regional
differences. In this report, European and U.S. scientists are asked about
planned purchases of both consumables and instrumentation, and from what
sources they expect to receive funding, with an emphasis on the ARRA.
Significantly, scientists also indicate from which supplier they plan to
purchase in each category - and why. Early results indicate that there are
clear winners in some of the product categories. special section is devoted to
the shift that was identified in our early 2009 budget report - an increase in
outsourcing to CRO' s. We asked labs what services have been outsourced in the
past two years, what services will be contracted over the next two years, and
how much influence labs have over a contractor' s choice of supplier,
instruments and consumables when performing work for the lab. We also gathered
their thoughts as to when they believe the recession will end for life
scientists - in the U.S. and in Europe, and how they feel about what' s in
store for 2011. In this report, scientists weigh-in on ways they are cutting
costs in the labs, and whether they feel these changes will be permanent, or
just temporary measures to weather the economic storm. Plus, in a spirit of
collaboration, suppliers have extended promotions and incentives to labs; find
out in this report which ones are working.
Comprised of responses from scientists with varying degrees of influence and
purchasing authority in the lab, The Market Outlook for Research Products
in FY2010 was designed to help you understand how labs are going to
allocate their budgets over the next fiscal year, how they are responding to
the economic recession and where they believe their organizations are headed
in FY2011.
This report will help you to:
- 1. Understand current sources of funding with a special focus on
ARRA funds.
- 2. Correlate scientists' projected budget for 2010 with anticipated
purchases in instrumentation and consumables - examining trends across 14
product categories with a focus on the vendors selected, the amount spent with
each vendor and the reasoning for the purchasing decision.
- 3. Identify practices scientists engaged in to conserve expenses
and which promotions were the most helpful, enabling suppliers to create
highly targeted marketing programs and promotions.
Methodology
The Market Outlook for Research Products in FY2010 is based on responses to a
50-question online survey conducted by BioInformatics, LLC. The questionnaire
was completed by 900 life scientists in the United States and Europe between
September 23 and 30, 2009. To be eligible to complete the questionnaire, all
respondents were required to demonstrate knowledge of the laboratory' s annual
budget and hold positions of authority in their laboratory. The questions were
answered by highly-qualified members of The Science Advisory Board™.
BioInformatics sponsors The Science Advisory Board™, an online community
of more than 45,000 scientists engaged in basic biological research, clinical
research and drug discovery and development. These experts have agreed to make
themselves available to answer questions including emerging areas of research,
the tools and techniques used in their labs, and their satisfaction with their
current suppliers.
Table of Contents
Section 1. Key Findings and Implications
Section 2. Methodology & Demographics
Section 3. Presentation of the Survey Data
Section 4. Appendices
- Appendix A.
- Appendix B.
- Appendix C.
